High-Altitude Maculopathy in Mountaineers: A Systematic Review and Meta-Analysis

Authors

  • Rataya Paramitha Maliawan Department of Ophthalmology, Faculty of Medicine, Universitas Udayana/Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Indonesia
  • I Made Ady Wirawan Faculty of Medicine, Universitas Udayana, Denpasar, Indonesia
  • I Gusti Ayu Made Juliari Department of Ophthalmology, Faculty of Medicine, Universitas Udayana/Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Indonesia
  • Ida Ayu Ary Pramita Department of Ophthalmology, Faculty of Medicine, Universitas Udayana/Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Indonesia

DOI:

https://doi.org/10.37275/bsm.v10i6.1613

Keywords:

High-altitude maculopathy, Meta-analysis, Mountaineering, Retinopathy, Systematic review

Abstract

Background: High-altitude maculopathy (HAM) represents a distinct form of high-altitude retinopathy affecting mountaineers at extreme elevations. Despite increased mountaineering activity, the prevalence and clinical significance of HAM remain poorly characterised in systematic reviews.

Methods: A comprehensive systematic review and meta-analysis were conducted following PRISMA 2020 guidelines. Databases searched included PubMed, Scopus, Cochrane Library, and manual review of reference lists through April 2026. Eligible studies were prospective and retrospective cohorts reporting HAM prevalence in mountaineers at altitude ≥3,500 metres. Risk of bias was assessed using the Newcastle-Ottawa Scale. Meta-analysis employed the Freeman-Tukey double arcsine transformation with DerSimonian-Laird random-effects modelling.

Results: Three prospective studies (n=50 mountaineers) were analysed with a pooled prevalence of 73.37% (95% confidence interval: 60.28–84.72%). Heterogeneity was absent (I²=0%, Q=0.78, p=0.678). Subgroup analysis demonstrated a higher prevalence at extreme altitude (≥5,000 m: 78.6%) versus very high altitude (3,500–4,999 m: 70%). Sensitivity ranged 67.48–83.76%. Funnel plot inspection revealed no evidence of publication bias.

Conclusion: Approximately three-quarters of mountaineers experience HAM at high altitude, with prevalence increasing at extreme elevations. HAM represents a common but underrecognised altitude-related ocular complication. Future prospective studies should employ standardised diagnostic criteria and investigate the mechanistic pathways of macular involvement.

Authors

  • Rataya Paramitha Maliawan1*
  • I Made Ady Wirawan2
  • I Gusti Ayu Made Juliari1
  • Ida Ayu Ary Pramita1
  1. 1Department of Ophthalmology, Faculty of Medicine, Universitas Udayana/Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Indonesia
  2. 2Faculty of Medicine, Universitas Udayana, Denpasar, Indonesia

Corresponding author Rataya Paramitha Maliawan — maliawanrataya@gmail.com

Article history

  1. Submitted
  2. Accepted
  3. Published

Downloads

Published

2026-04-23

Article metrics

185Abstract views
117PDF downloads

How to Cite

1.
Rataya Paramitha Maliawan, I Made Ady Wirawan, I Gusti Ayu Made Juliari, Ida Ayu Ary Pramita. High-Altitude Maculopathy in Mountaineers: A Systematic Review and Meta-Analysis. Bioscmed [Internet]. 2026 Apr. 23 [cited 2026 Aug. 12];10(6):2285-99. Available from: https://bioscmed.com/index.php/bsm/article/view/1613

Most read articles by the same author(s)

1 2 > >>